Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes

NCT04185337 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2025-02-27

No results posted yet for this study

Summary

This early phase I trial studies how well ultrasound-guided photoacoustic imaging works in telling the difference between healthy and cancerous inguinal (groin) lymph nodes and how well it can detect certain features of lymph nodes, including size and shape in patients with cancer. Ultrasound-guided photoacoustic is a non-invasive imaging method that can detect and display characteristics of lymph nodes based on the level of oxygen in the cells. This imaging method may provide more accurate tumor staging and prevent unnecessary surgical interventions.

Conditions

  • Malignant Neoplasm

Interventions

PROCEDURE

Fine-Needle Aspiration

Undergo ultrasound-guided FNA

PROCEDURE

Lymph Node Biopsy

Undergo ultrasound-guided lymph node biopsy

PROCEDURE

Photoacoustic Imaging

Undergo ultrasound-guided PAI

PROCEDURE

Ultrasound

Undergo ultrasound

DEVICE

Multispectral optoacoustic tomography (MSOT) acuity instrument

Use multispectral optoacoustic tomography (MSOT) acuity instrument

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Priya R Bhosale · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-26
Primary Completion
2025-02-25
Completion
2025-02-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04185337 on ClinicalTrials.gov